相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Avelumab maintenance in advanced urothelial carcinoma: biomarker analysis of the phase 3 JAVELIN Bladder 100 trial
Thomas Powles et al.
NATURE MEDICINE (2021)
Role of NRP1 in Bladder Cancer Pathogenesis and Progression
Yang Dong et al.
FRONTIERS IN ONCOLOGY (2021)
Advances in bladder cancer biology and therapy
Linda Tran et al.
NATURE REVIEWS CANCER (2021)
The rediscovery of platinum-based cancer therapy
Sven Rottenberg et al.
NATURE REVIEWS CANCER (2021)
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
Aurelie Kamoun et al.
EUROPEAN UROLOGY (2020)
Treatment of muscle-invasive and advanced bladder cancer in 2020
Vaibhav G. Patel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Stromal LAG-3+cells infiltration defines poor prognosis subtype muscle-invasive bladder cancer with immunoevasive contexture
Han Zeng et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy
Christopher A. Chuckran et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Neuropilin-1 is a T cell memory checkpoint limiting long-term antitumor immunity
Chang Liu et al.
NATURE IMMUNOLOGY (2020)
Bladder Cancer: A Review
Andrew T. Lenis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Discovery through clinical sequencing in oncology
Mark T. A. Donoghue et al.
NATURE CANCER (2020)
Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors
Dan Sha et al.
CANCER DISCOVERY (2020)
Determining cell type abundance and expression from bulk tissues with digital cytometry
Aaron M. Newman et al.
NATURE BIOTECHNOLOGY (2019)
Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1
Marine Leclerc et al.
NATURE COMMUNICATIONS (2019)
DNA damage repair gene mutations and their association with tumor immune regulatory gene expression in muscle invasive bladder cancer subtypes
Thiago Vidotto et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Identification and Validation of Stromal Immunotype Predict Survival and Benefit from Adjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer
Hangcheng Fu et al.
CLINICAL CANCER RESEARCH (2018)
Treatment resistance in urothelial carcinoma: an evolutionary perspective
Panagiotis J. Vlachostergios et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan et al.
NATURE (2018)
The immune contexture in cancer prognosis and treatment
Wolf H. Fridman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Multifaceted Role of Neuropilins in the immune System: Potential Targets for immunotherapy
Sohini Roy et al.
FRONTIERS IN IMMUNOLOGY (2017)
Bladder cancer
Oner Sanli et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Atezolizumab in platinum-treated locally advanced or metastatic urothelial carcinoma: post-progression outcomes from the phase II IMvigor210 study
A. Necchi et al.
ANNALS OF ONCOLOGY (2017)
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer
A. Gordon Robertson et al.
CELL (2017)
Guidance Molecule SEMA3A Restricts Tumor Growth by Differentially Regulating the Proliferation of Tumor-Associated Macrophages
Majken Wallerius et al.
CANCER RESEARCH (2016)
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
Jonathan E. Rosenberg et al.
LANCET (2016)
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
Lorenzo Galluzzi et al.
CANCER CELL (2015)
Whole-genome characterization of chemoresistant ovarian cancer
Ann-Marie Patch et al.
NATURE (2015)
Neuropilin-1 mediates myeloid cell chemoattraction and influences retinal neuroimmune crosstalk
Agnieszka Dejda et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Impeding Macrophage Entry into Hypoxic Tumor Areas by Sema3A/Nrp1 Signaling Blockade Inhibits Angiogenesis and Restores Antitumor Immunity
Andrea Casazza et al.
CANCER CELL (2013)
Completion of the entire hepatitis C virus life cycle in genetically humanized mice
Marcus Dorner et al.
NATURE (2013)
Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis
Greg M. Delgoffe et al.
NATURE (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
Neuropilin-1 is upregulated in hepatocellular carcinoma and contributes to tumour growth and vascular remodelling
Mathieu Berge et al.
JOURNAL OF HEPATOLOGY (2011)
Neuropilin-1 antagonism in human carcinoma cells inhibits migration and enhances chemosensitivity
H. Jia et al.
BRITISH JOURNAL OF CANCER (2010)